About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results 07-29-2026 at 4:05 PM EDT Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026 07-09-2026 at 4:05 PM EDT Imviva Biotech Receives FDA IDE Authorization for clonoSEQ® Assay in TENACITY-01 Clinical Trial 06-30-2026 at 8:30 AM EDT VIEW ALL NEWS Upcoming Events & Presentations More events are coming soon. Past Events & Presentations Adaptive Biotechnologies Second Quarter Financial Results Jul 29, 2026 at 4:30 PM EDT Listen to webcast Adaptive Biotechnologies Q2 2026 Earnings Presentation 872.3 KB William Blair 46th Annual Growth Stock Conference Jun 3, 2026 at 3:20 PM CDT Listen to webcast Presentation 2.4 MB Adaptive Biotechnologies First Quarter Financial Results May 5, 2026 at 4:30 PM EDT Listen to webcast Adaptive Biotechnologies Q1 2026 Earnings Presentation 533.1 KB VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Jul 30, 2026 12:37 AM EDTData Provided by Refinitiv. Minimum 15 minutes delayed.
